Stay updated on Nivolumab Plus Ipilimumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a behind-the-scenes update to the site; no study information or results are affected.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe revision history now lists a new Revision: v3.5.4, replacing the previous Revision: v3.5.3.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page’s footer revision label has been updated from version v3.5.2 to v3.5.3, indicating a minor platform/version update rather than a change to the study content.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check95 days agoChange DetectedUpdated the site revision tag from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Plus Ipilimumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.